Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Journal Reprints Shouldn’t See The Light Of Sunshine, Medical Societies Say

This article was originally published in The Gray Sheet

Executive Summary

Last-ditch effort to rewrite reg warns of unintended consequences from the reporting requirement.

You may also be interested in...



News Briefs: SGR Reform Bill Progress; CareFusion To Invest In Infusion Pump Firm

House and Senate committees approve long-term physician payment reform bills. CareFusion announces it will invest $100 million in infusion pump maker Caesarea Medical Electronics. More news.

Sunshine On Journal Article Reprints Could See Legal Challenge

Reprints are educational materials that doctors read for the benefit of their patients, Coalition for Healthcare Communication Executive Director John Kamp says, so CMS could have exempted them from the sunshine regulations.

Companies Dig Into Sunshine Rule Details In Preparation For Aug. 1 Go-Live Date

CMS has finalized several sunshine rule provisions: the definition of “applicable manufacturer” has been narrowed; many payments to speakers at continuing medical education programs and events need not be reported; and the agency will allow manufacturers to supply contextual information on the public database.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel